| abstract |
Described herein are compounds that are antagonists of the PGD 2 receptor. In addition, pharmaceutical compositions and drugs comprising the compounds described herein that are antagonists of the PGD 2 receptor are also described. Further, such PGD 2 receptor antagonists may be used alone or other to treat respiratory, cardiovascular, and other PGD 2 dependent or PGD 2 mediated diseases or disorders. A method for use in combination with a compound is described. [Selection figure] None |